The increasing demand for controlled immunological research and therapeutic design has spurred significant improvements in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using various expression systems, including microbial hosts, animal cell populations, and